About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Nashville | 763 Studies

Clinical Trials Breast CancerNashville

Breast Cancer Clinical Trials in Nashville

Find 763 clinical trials for breast cancer near Nashville, Tennessee. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Nashville

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 21-40 of 763 trials

UnknownA Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid TumorsThis is a study of navicixizumab monotherapy or in combination with paclitaxel or irinotecan in patients with advanced cancer.NCT05453825·Hot Springs, Arkansas and 7 others TerminatedStudy of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid TumorsThis study is an open-label, international, multi-center, Phase 2 study in adult patients with recurrent, locally-advanced or metastatic solid tumors, which harbor the NRG1 gene…NCT04383210·Birmingham, Alabama and 41 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedSurgical Site Infection With 0.05% Chlorhexidine (CHG) Compared to Triple Antibiotic IrrigationThe investigators intend to perform a prospective randomized study and compare the incidence of surgical wound infection between mastectomy wounds irrigated with triple antibiotic…NCT02395614·Nashville, Tennessee

Active not recruitingA Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial CancerThe reason for this study is to see if the study drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or…NCT04188548·Gilbert, Arizona and 73 others

CompletedLymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast CancerRATIONALE: Surgery to remove lymph nodes in the armpit may remove cancer cells that have spread from tumors in the breast.NCT00003855·Birmingham, Alabama and 155 others

CompletedA Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast CancerThis is a first-in-human, phase I/Ib clinical research study with BEZ235, an inhibitor of phosphatidylinositol 3'-kinase (PI3K).NCT00620594·Los Angeles, California and 14 others

RecruitingSaruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast CancerThe primary objective of the study is to measure efficacy of saruparib (AZD5305) plus camizestrant compared with physician's choice CDK4/6i plus ET in patients with BRCA1, BRCA2…NCT06380751·Gilbert, Arizona and 305 others

RecruitingCirculating Tumor DNA to Guide Changes in Standard of Care ChemotherapyThis phase II trial tests how well evaluating circulating tumor deoxyribonucleic acid (ctDNA) works to guide therapy-change decisions in treating patients with triple-negative…NCT05770531·Nashville, Tennessee

CompletedCAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)The objective of this study is to assess safety and efficacy of CAB-ROR2-ADC in solid tumorsNCT03504488·Tucson, Arizona and 58 others

CompletedA Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast CancerThe main purpose of this study is to evaluate the safety and efficacy of abemaciclib plus tamoxifen or abemaciclib alone in women with previously treated hormone receptor-positive…NCT02747004·Tucson, Arizona and 58 others

RecruitingA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid TumorsThe purpose of this study is to assess the safety, tolerability, and recommended dose(s) of BMS-986340 as monotherapy and in combination with nivolumab, docetaxel, or Pumitamig in…NCT04895709·Clovis, California and 46 others

TerminatedGefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the BreastRATIONALE: Gefitinib may stop the growth of tumor cells by blocking the enzymes necessary for their growth.NCT00082667·Nashville, Tennessee and 1 other

CompletedA Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid TumorsThis is a Phase 1b/2, multi-center study to assess the safety and efficacy of ibrutinib in combination with durvalumab (MEDI4736) in participants with relapsed or refractory solid…NCT02403271·Birmingham, Alabama and 16 others

CompletedSafety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid TumoursThis is an open-label, multi-centre, Phase Ib study of AZD1775 designed to assess the safety, tolerability, pharmacokinetics, and anti-tumour activity of AZD1775 monotherapy in…NCT02482311·Fayetteville, Arkansas and 15 others

TerminatedA Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid TumorsThis was a multi-center, open-label, phase Ib/II study.NCT01708161·Los Angeles, California and 9 others

CompletedTrial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant ChemotherapyThe investigators propose to evaluate eribulin as adjuvant therapy in breast cancer patients who have residual invasive disease in breast or lymph node tissue following standard…NCT01401959·Fort Myers, Florida and 17 others

CompletedA Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)The purpose of this study was to combine the PDR001 checkpoint inhibitor with each of four agents with immunomodulatory activity to identify the doses and schedule for combination…NCT02900664·Baltimore, Maryland and 22 others

TerminatedPROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid TumorsThe purpose of this first-in-human study of CX-2009 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-2009 in…NCT03149549·Los Angeles, California and 25 others

TerminatedStudy of Safety and Efficacy of Novel Immunotherapy Combinations in Patients With Triple Negative Breast Cancer (TNBC).This is a Phase Ib, open label, dose escalation study of spartalizumab + LAG525 in combination with NIR178, capmatinib, MCS110, or canakinumab, followed by a dose expansion in…NCT03742349·New York, New York and 12 others

CompletedGrowth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial CancerRATIONALE: Measuring levels of transforming growth factor-beta (TGF-beta) in the blood of patients with epithelial cancers (head and neck, lung, breast, colorectal, and prostate)…NCT00897793·Nashville, Tennessee and 2 others

PreviousPage 2 of 39Next

Other Conditions in Nashville

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma